LegisTrack
Back to all bills
HR 1525119th CongressIn Committee

Protecting Life from Chemical Abortions Act

Introduced: Feb 24, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

The Protecting Life from Chemical Abortions Act would (1) bar the Secretary of Health and Human Services from using or declaring a federal public health emergency related to abortion, and would terminate any such emergency already in effect, and (2) impose new restrictions on abortion drugs under the FDA’s risk evaluation and mitigation strategy (REMS) for these drugs. Specifically, it requires in-person dispensing of abortion drugs by certified health care providers, prohibits the Department from easing REMS protections, and ties any loosening of protections to a mandatory state data submission to CDC’s abortion surveillance system using a standardized data worksheet with defined variables. The bill also creates detailed definitions of key terms (abortion, abortion drug, certified health care provider, unborn child) and sets forth the data collection variables to be used in reporting. In short, the bill would roll back federal public health emergency authority related to abortion and impose stricter controls and data requirements on abortion-drug use.

Key Points

  • 1Prohibition of federal public health emergency related to abortion: The Secretary may not use or declare a public health emergency under the Public Health Service Act with respect to abortion, and any such current declaration would be terminated upon enactment.
  • 2In-person dispensing requirement for abortion drugs: The bill requires that abortion drugs be dispensed only in clinics, medical offices, or hospitals by or under the supervision of a certified health care provider, reversing any previous allowance for dispensing outside in-person settings.
  • 3Prohibition on relaxing REMS protections: The Secretary and other HHS officials may not exercise enforcement discretion to weaken any requirement under the abortion-drug REMS, and must reinstate the in-person dispensing requirement on enactment.
  • 4State data submission before relaxing protections: The bill bars reducing REMS protections unless every state submits aggregated abortion data to the CDC abortion surveillance system using a standardized worksheet with specified variables.
  • 5Mandatory data variables and definitions: It sets a list of required data points (e.g., maternal age, gestational age, race/ethnicity, abortion method, prior pregnancies, residence, whether the child survived, congenital anomalies) and defines key terms (abortion, abortion drug, certified health care provider, unborn child) with specific criteria and qualifications for providers.

Impact Areas

Primary group/area affected: Individuals seeking abortions (patients) may experience reduced access to abortion drugs, particularly where in-person dispensing is limited or where providers are scarce; health care providers and clinics that perform abortions would face new certification and dispensing requirements and must adhere to stricter REMS controls.Secondary group/area affected: Federal and state health agencies (HHS, FDA, CDC) would implement and enforce the REMS restrictions, in-person dispensing rules, and the new data-collection requirements; states would be involved in collecting and submitting standardized abortion data to the CDC.Additional impacts: The act could affect telemedicine abortion practices and access in rural or underserved areas, potentially increasing travel and wait times for patients. It also formalizes a definitional framework around abortion and unborn life that could influence ongoing policy debates and litigation. The data-collection requirements would impose additional reporting burdens on states and health systems.
Generated by gpt-5-nano on Nov 19, 2025